PubMed Health⌕ Search

Biomedical subjects

G Koubi

Publications and source records attributed to G Koubi.

14 recordsLinked to original sources
PubMed1997

Comparison of the intraosseous biocompatibility of Vitremer and super EBA by implantation into the mandible of rabbits.

OBJECTIVES: This study compared the intraosseous biocompatibility of Vitremer, a new hydrophilic glass-ionomer cement, to that of Super EBA. STUDY DESIGN: Twenty-two New Zealand rabbits were anesthetized, the mandibular bone exposed, and two holes were drilled through the cortical plate. The materials were loaded into silicone carriers and inserted into the mandibles. Eleven rabbits were killed 4 weeks after implantation, 11 animals after 12 weeks. The mandibles were prepared with standard histologic procedures; the tissue reactions were graded from none to very severe. RESULTS: At 4 weeks Vitremer implants showed very slight to slight reactions, and the Super EBA implants showed slight reactions and one moderate reaction with no significant difference between the two materials. At 12 weeks, bone healing had occurred, despite the persistence of some fibrous tissue interposition. The reactions were classified as none to very slight for Vitremer and very slight to slight for EBA. Statistical analysis showed better results for Vitremer at 12 weeks. CONCLUSION: The intraosseous biocompatibility of Vitremer was similar at 4 weeks and superior at 12 weeks to that of Super EBA. Its other properties should be evaluated before considering its use in clinical practice.

Animals↗
PubMed1996

The use of a resorbable membrane in mucogingival surgery. Case series.

A surgical technique involving a resorbable membrane was used to treat 3 to 7 mm localized human buccal recessions on 10 consecutive patients. The exposed root surface was scaled and a trapezoidal mucoperiosteal flap was elevated after de-epithelization of the papillae. The space between the root and the membrane was created using a bur to form a concavity on the root and by bending the membrane with a suture. The flap was positioned as coronally as possible covering the membrane. The sutures were removed 15 days postsurgery and tetracycline therapy prescribed for 10 days. The results were evaluated at 12 months. The surgical procedure resulted in a significant reduction in recession (2.9 mm +/- 1.3) as well as a gain in attachment (3.4 mm +/- 2.1). Calculation of mean root coverage was 59.6%. There was no significant change of the keratinized tissue width. For therapeutic reasons, re-entry was performed in 2 cases: newly formed tissue was observed on the previously exposed roots. Guided tissue regeneration using a resorbable membrane appears to provide good results in cases of localized buccal recession.

Adult↗
PubMed1987

[Modification of the level of adenosine triphosphate in digital pulp capillary blood in patients with microcirculatory disorders following i.v. injection of coenzyme A (CoA 1000)].

Capillary blood ATP assay was performed in 2 groups of patients (diabetic and non-diabetic) with disorders of microcirculation, before and several minutes after 2 mg I.V. of Coenzyme A (CoA 1000). Values obtained showed a significant increase in both groups. The hypothesis advanced, based on previous experimental data indicating an action of CoA on intracellular calcium movement, is that CoA 1000 acts by elevation of the membrane ATP/Ca+ ratio of red corpuscles, and possible activation of their deformability and flow rate in the microcirculation.

Adenosine Triphosphate↗
PubMedDate not supplied

[Hormones and venous system].

Sex hormones have an effect on venous "content" and "container" according to their chemical nature, their dosage and their mode of administration: 17 beta-estradiol (endogenous): protective effect; synthetic estrogens, at normal or low doses: thrombogenic; oral natural estrogens: thrombogenic; extra-digestive natural estrogens: non thrombogenic; non steroid progestagens (androgenic): thrombogenic; non androgenic progestagens: non thrombogenic. Clinically, the venous disease si characterized by sudden episodes occurring at key-periods of the hormonal life: puberty, pregnancy, menopause, oral contraceptives intake, substitute treatments of menopause, premenstrual syndrome. Evaluation of these different situations shows that an early treatment is possible and needed, which, although not providing a new venous wall for these constitutionally fragile patients, may act effectively at two levels: 1) correction of the haemodynamic disorder (venous reflux in the saphenous arches and the perforators; 2) resorption of tissue infiltration. As primary prevention, in a patient with hormonal disorders or who must be treated with estrogens or progestagens, the objective of our treatment is to protect the venous wall and encourage the return circulation. One must: 1) reinforce the vaso-constrictive effect and the parietal tone, 2) limit collagen and elastin alteration, 3) reinforce capillary permeability and decrease the interstitial edema, 4) normalize the haemorheological constants, 5) restore the balance hemostasis-fibrinolysis. The opinion of a phlebologist seems essential before prescribing a hormonal treatment and monitoring the effects of the treatment. Cooperation between gynaecologists and phlebologists is particularly essential in the interpretation of the clinical disorders as well as discussing the venous risk, the dosage and the administration route of sex hormones.

Catecholamines↗